Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Rxsight Inc
RXSTCurrent price
45.05 USD
+0.13 USD (+0.29%)
Last closed
44.16 USD
Company
www.rxsight.com
ISIN
US78349D1072
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
1 935 019 008 USD
Yield for 12 month
+60.15 %
1Y
3Y
5Y
10Y
15Y
RXST
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Address: 100 Columbia, Aliso Viejo, CA, United States, 92656
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
63 USDP/E ratio
–Dividend Yield
–Current Year
+89 077 000 USD
Last Year
+49 005 000 USD
Current Quarter
+45 408 000 USD
Last Quarter
+34 887 000 USD
Current Year
+53 765 000 USD
Last Year
+21 328 000 USD
Current Quarter
+25 220 000 USD
Last Quarter
+24 250 000 USD
Key Figures RXST
1 year
3 years
5 years
10 years
EBITDA
-34 971 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.92 %
PEG Ratio
–
Return On Equity TTM
-13.99 %
Wall Street Target Price
63 USD
Revenue TTM
128 293 000 USD
Book Value
6.89 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
59.1 %
Dividend Yield
–
Gross Profit TTM
21 328 000 USD
Earnings per share
-0.81 USD
Diluted Eps TTM
-0.81 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-23.92 %
Dividend Analytics RXST
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RXST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RXST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
104.1667
Enterprise Value Revenue
13.3226
Price Sales TTM
15.0828
Enterprise Value EBITDA
-7.7044
Price Book MRQ
6.979
Financials RXST
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RXST
For 52 weeks
26.2 USD
66.54 USD
50 Day MA
51.2 USD
Shares Short Prior Month
2 257 462
200 Day MA
52.88 USD
Short Ratio
5.15
Shares Short
2 193 075
Short Percent
5.8 %
BeatStart